CRL vs. XLV

Last updated Jun 4, 2026

CRL (Charles River Laboratories International, Inc.) is a stock, while XLV (State Street Health Care Select Sector SPDR ETF) is Health & Biotech Equities fund tracking the Health Care Select Sector Index. Over the past 10 years, CRL returned 7.68%/yr vs 9.20%/yr for XLV. At a 0.49 correlation, their price movements are largely independent.

Performance

CRL vs. XLV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Charles River Laboratories International, Inc. (CRL) and State Street Health Care Select Sector SPDR ETF (XLV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRL achieves a -9.83% return, which is significantly lower than XLV's -4.29% return. Over the past 10 years, CRL has underperformed XLV with an annualized return of 7.68%, while XLV has yielded a comparatively higher 9.20% annualized return.

CRL

• 1D: 2.91%
• 1M: 4.38%
• YTD: -9.83%
• 6M: -2.60%
• 1Y: 29.88%
• 3Y*: -3.58%
• 5Y*: -11.79%
• 10Y*: 7.68%

XLV

• 1D: 0.79%
• 1M: 1.95%
• YTD: -4.29%
• 6M: -4.06%
• 1Y: 12.89%
• 3Y*: 5.98%
• 5Y*: 5.55%
• 10Y*: 9.20%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRL vs. XLV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CRL Charles River Laboratories International, Inc.	-9.83%	8.06%	-21.91%	8.49%	-42.17%	50.80%	63.56%	34.97%	3.41%	43.65%
XLV State Street Health Care Select Sector SPDR ETF	-4.29%	14.50%	2.47%	2.07%	-2.08%	26.04%	13.30%	20.45%	6.28%	21.77%

Correlation

The correlation between CRL and XLV is 0.48, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.48
Correlation (3Y) Calculated over the trailing 3-year period	0.48
Correlation (5Y) Calculated over the trailing 5-year period	0.52
Correlation (10Y) Calculated over the trailing 10-year period	0.57
Correlation (All Time) Calculated using the full available price history since Jun 26, 2000	0.49

The correlation between CRL and XLV has been stable across timeframes, ranging from 0.48 to 0.57 - a consistent structural relationship.

Return for Risk

CRL vs. XLV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRL

CRL Risk / Return Rank: 59
CRL Sharpe Ratio Rank: 62
CRL Sortino Ratio Rank: 57
CRL Omega Ratio Rank: 58
CRL Calmar Ratio Rank: 59
CRL Martin Ratio Rank: 58

XLV

XLV Risk / Return Rank: 24
XLV Sharpe Ratio Rank: 24
XLV Sortino Ratio Rank: 26
XLV Omega Ratio Rank: 23
XLV Calmar Ratio Rank: 26
XLV Martin Ratio Rank: 23

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRL vs. XLV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Charles River Laboratories International, Inc. (CRL) and State Street Health Care Select Sector SPDR ETF (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRL	XLV	Difference
Sharpe ratio Return per unit of total volatility	0.67	0.88	-0.21
Sortino ratio Return per unit of downside risk	1.17	1.42	-0.25
Omega ratio Gain probability vs. loss probability	1.15	1.16	-0.01
Calmar ratio Return relative to maximum drawdown	0.89	1.24	-0.35
Martin ratio Return relative to average drawdown	1.85	2.99	-1.14
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CRL vs. XLV - Sharpe Ratio Comparison

The current CRL Sharpe Ratio is 0.67, which is comparable to the XLV Sharpe Ratio of 0.88. The chart below compares the historical Sharpe Ratios of CRL and XLV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CRL	XLV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.67	0.88	-0.21
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.28	0.38	-0.66
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.20	0.56	-0.35
Sharpe Ratio (All Time) Calculated using the full available price history	0.24	0.46	-0.22

Drawdowns

CRL vs. XLV - Drawdown Comparison

The maximum CRL drawdown since its inception was -78.23%, which is greater than XLV's maximum drawdown of -39.17%. Use the drawdown chart below to compare losses from any high point for CRL and XLV.

Drawdown Indicators

	CRL	XLV	Difference
Max Drawdown Largest peak-to-trough decline	-78.23%	-39.17%	-39.06%
Max Drawdown (1Y) Largest decline over 1 year	-33.88%	-10.47%	-23.41%
Max Drawdown (3Y) Largest decline over 3 years	-63.52%	-17.11%	-46.41%
Max Drawdown (5Y) Largest decline over 5 years	-78.23%	-17.11%	-61.12%
Max Drawdown (10Y) Largest decline over 10 years	-78.23%	-28.40%	-49.83%
Current Drawdown Current decline from peak	-60.75%	-7.52%	-53.23%
Average Drawdown Average peak-to-trough decline	-25.72%	-7.12%	-18.60%
Ulcer Index Depth and duration of drawdowns from previous peaks	16.23%	4.32%	+11.91%

Volatility

CRL vs. XLV - Volatility Comparison

Charles River Laboratories International, Inc. (CRL) has a higher volatility of 17.68% compared to State Street Health Care Select Sector SPDR ETF (XLV) at 4.10%. This indicates that CRL's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRL	XLV	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.68%	4.10%	+13.58%
Volatility (6M) Calculated over the trailing 6-month period	34.98%	10.24%	+24.74%
Volatility (1Y) Calculated over the trailing 1-year period	44.98%	14.67%	+30.31%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	42.71%	14.69%	+28.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	37.74%	16.55%	+21.19%

Dividends

CRL vs. XLV - Dividend Comparison

CRL has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.70%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CRL Charles River Laboratories International, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
XLV State Street Health Care Select Sector SPDR ETF	1.70%	1.60%	1.67%	1.59%	1.47%	1.33%	1.49%	2.17%	1.57%	1.47%	1.60%	1.43%

Frequently Asked Questions

Can I hold both CRL and XLV in my portfolio?

CRL and XLV have a correlation of 0.48, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRL or XLV?

CRL has higher volatility (17.68%) compared to XLV (4.10%). In terms of maximum drawdown, CRL dropped -78.23% vs XLV's -39.17%.

Which has better risk-adjusted returns?

XLV currently has the higher Sharpe Ratio (0.88 vs 0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.